Depew Ian, Snider William T, Cook Shane
Department of Dermatology, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Cureus. 2024 Oct 14;16(10):e71430. doi: 10.7759/cureus.71430. eCollection 2024 Oct.
Anaplastic large cell lymphoma (ALCL) is a rare T-cell lymphoma characterized by CD30 expression. This report describes the case of a 10-year-old female who presented with non-resolving cutaneous lesions initially treated as a bacterial infection. A biopsy confirmed the diagnosis of anaplastic lymphoma kinase-negative (ALK-negative) ALCL with cutaneous and nodal involvement. Further imaging revealed neoplastic uptake in the right lung, and the patient was diagnosed with Murphy stage II ALCL. She began chemotherapy according to established pediatric oncology protocols. ALCL presents diagnostic challenges due to its non-specific symptoms, which can mimic benign conditions. This case underscores the importance of early biopsy and molecular testing when standard treatments fail. Early recognition and routine examinations, including lymph node assessments and skin biopsies, are critical for improving patient outcomes, as timely diagnosis leads to more effective treatment options and potential remission.
间变性大细胞淋巴瘤(ALCL)是一种罕见的以CD30表达为特征的T细胞淋巴瘤。本报告描述了一名10岁女性病例,该患者最初出现无法消退的皮肤病变,最初被当作细菌感染进行治疗。活检确诊为伴有皮肤和淋巴结受累的间变性淋巴瘤激酶阴性(ALK阴性)ALCL。进一步的影像学检查显示右肺有肿瘤摄取,该患者被诊断为墨菲II期ALCL。她开始按照既定的儿科肿瘤学方案进行化疗。由于ALCL的症状不具特异性,可类似良性疾病,因此在诊断上存在挑战。该病例强调了在标准治疗失败时早期活检和分子检测的重要性。早期识别和常规检查,包括淋巴结评估和皮肤活检,对于改善患者预后至关重要,因为及时诊断可带来更有效的治疗选择和潜在的缓解。